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Abstract 
(Structured as Background, Objectives, Methods, Results, Conclusions) 
Background: The transmembrane G-protein coupled adenosine A2A Receptors (A2AR) 
are one of the main brain targets of adenosine, an homeostatic neuromodulator 
(Fredholm et al., 2007). Evidence was found of upsurge of A2AR expression, 
accompanied by coupling and affinity alterations associated to cognitive deficits in 
ageing (Diógenes et al., 2007; Lopes et al., 1999b) and neurodegeneration, namely 
Alzheimer’s Disease (Eskelinen et al., 2009). However, it is not known whether A2AR 
are involved in the development of pathology and aging phenotype; and if the 
overexpression happens as cause or a consequence of disease.  
Objectives: Test the hypothesis that inducing neuronal A2AR overexpressing in the 
forebrain (CAMkIIa promoter driven human A2A receptor rats) is sufficient to mimic 
functional and structural changes observed in aged rats.  
Methods: Radioligand binding of [3H] ZM241385 (antagonist of A2AR) to perform 
saturation and competition assays in neuronal membranes from striatum and 
hippocampus of wild-type (WT) and A2AR over-expression transgenic rats (TG).  
Results: Saturation binding for A2AR, showed an increase in Bmáx of the TG 
compared to WT both in the striatum (1249±79 and 931,6±72,9 fmol/mg, n=3) and the 
hippocampus (731,2±156,1  fmol/mg versus undetectable levels in WT). The affinity 
constant (KD) was similar in the striatum (0,123±0,045 nM) of TG and WT (0,106±0,05 
nM); whereas in the  hippocampus it was 0,62±0,39 nM  for TG (n=3).  
Studies of Competition with GppNHp were performed to investigate the coupling of 
A2AR to G-proteins. In the striatum, the GTP shift1 was 166% (n=4) in WT and it was 
superior in TG: 194 (n=4). Analytical comparison showed significant difference (p-value 
of 0,03). In the hippocampus, TG GTP shift was 211% (n=4), showing no significant 
difference from the striatum of TG. 
Conclusions: The major conclusion of the present study is that over-expression of 
A2A receptors in the forebrain induces increased coupling of G-protein to A2AR in 
striatum and hippocampus. This profile is similar to the one found in aged animals 
(Lopes et al., 1999b), albeit with lower magnitude. This suggests the contribution of 
other factors, besides over-expression, to the modification of GTP binding profile. 
 
 
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  The GTP shift was calculated as the ratio of Ki value in the presence of Gpp(NH)p per the Ki 
value in the absence of Gpp(NH)p which shifts high-affinity G-protein coupled receptors to low-
affinity uncoupled receptors.	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Introdução: Os receptores transmembranares de adenosina do subtipo A2A (A2AR) 
acoplados a proteína G constituem um dos principais alvos da adenosina, um 
neuromodulador homeostático (Fredholm et al., 2007). Estudos determinaram que 
existe uma associação entre a sobre-expressão de A2AR, alterações do acoplamento e 
afinidade; e os défices cognitivos da senescência (Diógenes et al., 2007; Lopes et al., 
1999b) e neurodegeneração, nomeadamente na doença de Alzheimer (Eskelinen et 
al., 2009). 
No entanto, ainda não está definido se os A2AR estão envolvidos no desenvolvimento 
de patologia e senescência; e se a sobre-expressão ocorre como causa ou 
consequência da doença. 
Objectivos: Testar a hipótese de que a indução da sobre-expressão neuronal de A2AR 
no prosencéfalo (promotor CAMkIIa derivado dos humanos em receptor de A2A de 
ratos) é suficiente para reproduzir as modificações estruturais e funcionais observados 
nos ratos senescentes. 
Métodos: Ensaios de ligação com o radioligando de [3H] ZM241385 (antagonista de 
A2AR) para ensaios de saturação e competição em membranas neuronais de regiões 
do estriado e hipocampo de ratos selvagens (WT) e ratos transgénicos que sobre-
expressam A2AR com o objectivo de avaliar densidade de receptores e acoplamento a 
proteínas G. 
Resultados: Ensaios de saturação para A2AR, mostram um aumento em Bmáx de TG 
comparado com WT no estriado (1249±79 and 931,6±72,9 fmol/mg, n=3) bem como 
no hipocampo (731,2±156,1 fmol/mg versus níveis indetectáveis nos WT). A constante 
de afinidade (KD) determinada é semelhante no estriado de TG (0,123±0,045 nM) e 
WT(0,106±0,05 nM); enquanto que no hipocampo foi 0,62±0,39 nM para TG (n=3). 
Ensaios de Competição com GppNHp foram realizados para investigar o acoplamento 
de A2AR a proteína G. No estriado, o GTP shift foi de 166 (n=4) no WT e era superior 
em TG: 194 (n=4). A comparação analítica dos dados revelou diferença significativa 
(p-value de 0,03). No hipocampo, o GTP shift foi de 211 (n=4), sem diferença 
significativa em relação ao estriado dos TG. 
Conclusões: A principal conclusão do estudo é de que a sobre-expressão de 
receptores A2A no prosencéfalo induz o aumento do acoplamento da proteína G de A2A 
no estriado e hipocampo. Este perfil é semelhante ao encontrado em animais 
senescentes (Lopes et al., 1999b), ainda que de menor magnitude. Isto sugere a 
contribuição de outros factores, para além da sobre-expressão, na modificação do 
perfil de ligação ao GTP. 
 
 
 
Abbreviations: A1Rs – Adenosine A1 receptors; A2ARs – Adenosine A2A receptors; CGS 
21680 – 2-[4-(2-P-carboxyethyl)phenylamino]-50-N-ethylcarboxamidoadenosine; CGS 15943 – 
9-chloro-2-(2-furyl)(1,2,4)triazolo(1,5-c)quinazolin-5-amine; [3H]ZM241385 - 4-[2-[7-[2-3H]-
Amino-2-(2-furyl)[1,2,4] triazolo[2,3-a][1,3,5]triazin-5-ylamino]-ethyl]phenol; Bmáx.- maximum 
value of binding; GTP- G-protein; KD - affinity constant; Ki;  WT- Wild-type Animals; TG-  
Transgenic Animals
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Introduction 
Ageing is associated with cognitive 
decline both in humans and animals. 
The cognitive impairments observed with 
age and neurodegenerative diseases are 
accompanied by structural and functional 
alterations in the hippocampus, that 
directly affect neural plasticity (Burke and 
Barnes, 2006), leading to synaptic 
dysfunctions and, subsequently, memory 
deficits (Diogenes et al., 2011). 
The present study focuses on the role of 
adenosine in the realm of 
neuroprotection.   
This homeostatic neuromodulator acts 
predominantly via two known receptors 
with opposite physiological actions: 
inhibitory A1 and facilitatory A2A receptors 
(Ribeiro et al., 1996). 
Adenosine A2A Receptors (A2AR) are one 
of the main brain targets of adenosine 
(Fredholm et al., 2007). A2AR are 
constitutively activated G-protein 
coupled-receptors, preferentially 
expressed by the striatopallidal medium 
spiny striatal neurons (Blum et al., 2003; 
Schiffmann and Vanderhaeghen, 1993) 
but they are also present throughout the 
brain albeit with a considerably lower 
density. 
However, compelling evidence was found 
that, upon ageing, there is cortical and 
hippocampal upsurge of A2AR 
expression/function and changes in its 
affinity profile associated to the cognitive 
deficits observed (Cunha et al., 1995; 
Lopes et al., 1999b). 
Specifically, in the hippocampus of aged 
rats, A2AR expression is nearly two fold 
than of young ones (Cunha et al., 1995; 
Lopes et al., 1999b). Interestingly, other 
detrimental conditions associated to 
cognitive impairments, such as hypoxia, 
diabetes, stress or epilepsy share similar 
A2AR overactivation (Batalha et al., 2013; 
Lopes et al., 1999a; Lopes et al., 2011). 
Recently, it was described impairment of 
long-term potentiation (LTP) and 
hippocampal dependent tasks in an 
early-aging model, associated with 
increased A2AR hippocampal expression 
(Batalha et al., 2013).  
The relevance of adenosine in 
physiological and pathological processes 
of the nervous system was 
acknowledged when pioneer studies 
recognized an inverse relation between 
the consumption of caffeine, an A2AR 
antagonist, and the risk for development 
of Parkinson Disease (Ascherio et al., 
2001; Ross and Petrovitch, 2001) and 
Alzheimer’s Disease (Eskelinen et al., 
2009; Lindsay et al., 2002; Maia and de 
Mendonça, 2002). It is now well 
established that under normal habitual 
caffeine consumption, the effects exerted 
in the brain by caffeine depend on its 
ability to block adenosine A1 and A2A 
receptors (Fredholm et al., 1999). 
Moreover, the  beneficial impact of A2A 
receptor deletion or anti-A2A therapeutics 
in transgenic mouse models of AD-like 
pathology was recently proven (Laurent 
et al., 2016; Matos et al., 2012) 
Strikingly, recent studies in animal 
models, showed that it was possible to 
restore synaptic and cognitive 
dysfunction by blocking A2AR with the 
selective antagonist KW6002 (Batalha et 
al., 2013) orally administered for one 
month. 
This supports an instrumental role of 
A2AR dysregulation in the genesis of 
synaptic dysfunction underlying cognitive 
impairments. However, the mechanism 
involved or whether A2AR upsurge is 
sufficient to accelerate hippocampal 
aging is yet unknown. 
The ultimate question that is being 
addressed is whether the increase in 
A2AR is either the cause or a 
consequence for the development of 
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pathology and aging. To address this, we 
established a novel transgenic rat strain 
TGR(CamKIIhA2A), overexpressing 
adenosine A2AR under the control of the 
CamKII promotor. The animals display 
learning impairments but it remains to be 
established if this is associated with 
modifications in the affinity profile of the 
receptor similar to those found in aged 
animals in literature. 
So I tested this model to determine 
whether A2AR density, affinity for ligand 
and G-protein coupling is modified as it 
was found in aged rats. To assess this 
possibility, the model was tested for 
A2AR’s density using binding experiments 
of the saturation type and the variation in 
G protein coupling to A2A receptors was 
determined using binding experiments of 
the competition type. 
Methods 
Animals: Animal procedures were 
performed within the rules of the 
Portuguese official veterinary 
department, which complies with 
European Directive 2010/63/EC and the 
Portuguese law transposing this Directive 
(DL 113/2013), and approved by the 
Instituto de Medicina Molecular Internal 
Committee and the Portuguese Animal 
Ethics Committee (Direcção Geral de 
Veterinária). Environmental conditions 
were kept constant: food and water ad 
lib, 21±0.5°C, 60±10% relative humidity, 
12 h light/dark cycles. Male rats were 
killed by decapitation after anesthesia 
under halothane atmosphere. 
Generation and maintenance of 
transgenic animals: Transgenic rats 
with an overexpression of adenosine 
A2A receptors (A2AR) under the control 
of the CaMKII promotor, tg(CaMKII-
hA2AR), were generated by 
microinjection of a linearized DNA 
construct into the male pronucleus of 
Sprague–Dawley rat zygotes with 
established methods (Popova et al., 
2002). The construct contained a full-
length human A2A cDNA cloned into an 
expression vector with the 8.5 kb 
mouse CaMKIIα promoter (Mayford et 
al., 1996) and a polyadenylation 
cassette of bovine growth hormone 
(Coelho et al., 2014). Wild type (WT) 
littermates were used as controls. 
Genotyping: Transgenic rats were 
identified by PCR (30 cycles, 58 °C 
annealing temperature) of their 
genomic DNA isolated from ear 
biopsies by the use of the following 
transgene-specific primers: CaMKII-
hA2A and rat Act-B  primers as an 
internal control (Invitrogen, UK, see 
supplementary Table 1). 
Chemicals:  
4-[2-[7-[2-3H]-Amino-2-(2-furyl)[1,2,4] 
triazolo[2,3-a][1,3,5]triazin-5-ylamino]-
ethyl]phenol ([3H]ZM241385; specific 
activity, 17 Ci/mmol) was from Tocris 
Cookson (Bristol, U.K.).  
Adenosine deaminase (ADA; type VI, 
1,803 U/ml, EC 3.5.4.4),59-guanylylimido 
diphosphate [Gpp(NH)p], and hemicho-
linium-3 were from Sigma (St. Louis, MO, 
U.S.A.). 
8-[4-[(2-Aminoethyl)amino]carbonyl 
methyloxyphenyl]xanthine (XAC) and 
CGS21680 were from Research 
Biochemicals International 
(Natick, MA, U.S.A.). 
 
Membrane binding experiments 
[3H] ZM241385 binding studies of the 
saturation and competition type were 
performed as previously described 
(Cunha et al., 1995), using membranes 
from striatum and hippocampus of wild-
type and A2A over-expressive transgenic 
rats.  
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Briefly, brains were removed from 12 rats 
of each genoype and the striata and 
hippocampus were dissected out at 4ºC 
in sucrose solution (0,32 M) containing 
50 mM Tris-HCl, 2 mM EGTA, pH 7,6. 
The tissue was homogenized in a potter-
elvehjem homogenizer at 4ºC. The 
resulting homogenates were centrifuged 
at 1000 x g for 10 min. at 4ºC. The 
supernatants were re-centrifuged at 
14000 x g for 12 min. at 4ºC. The pellets 
were then resuspended in a solution 
containing 50 mM Tris-HCl (pH 7,4), 2 
mM EGTA, 1 mM EDTA, 2 Uml ‘ ADA 
and incubated for 30 min. at 37ºC to 
remove endogenous adenosine. After 
centrifugation at 14000 x g the pellets 
were resuspended in the incubation 
solution (pH 7,4) containing 50 mM Tris-
HCl, 2 mM (saturation) or 10 mM 
(competition) of MgCl2 and 2 Uml ‘ ADA. 
Aliquots were then frozen and stored at -
20 ºC for the studies of the saturation 
type. Fresh samples were used for the 
studies of the competition type. 
In the studies of the saturation type 
samples were incubated with 7 
concentrations of the antagonist [3H] 
ZM241385 from 0-7nM for 1 h at room 
temperature. In the studies of the 
competition type samples were incubated 
with [3H] ZM 241385 6 nM and 12 known 
concentrations of A2AR agonist CGS 
21680 from 0-6 µM and with either buffer 
or Gpp(NH)p 600 µM .This was 
performed with 40-10 µg of membrane 
protein for striatum and 300-100 µg for 
hippocampus in a final volume of 300 µL 
in an incubation solution of Tris/Mg 
solution. Non-specific binding of A2A 
receptor antagonist [3H]ZM 241385 was 
measured with A1/A2 receptor antagonist 
XAC (12 µM). All binding assays were 
performed in duplicate. The binding 
reactions were stopped by vacuum 
filtration. The washing volume was of 5 
mL per well in both the experiments of 
the saturation and the competition type, 
with the respective incubation buffer 
maintained at 4°C. The filters were 
placed in scintillation liquid (Ready Safe, 
Wallac, Finland) and radioactivity was 
determined after at least 12 h of 
incubation. The counting efficiency was 
of 61%. The protein concentration was 
determined using the Bio-Rad protein 
assay based on Bradford dye-binding 
procedure. 
The specific binding was fitted by non-
linear regression to a one-site binding 
equations using the Raphson-Newton 
method, performed with commercial 
software (GraphPad San Diego, CA, 
U.S.A.). Data are the mean ± s.e.m. 
values (95% confidence interval) of n 
experiments. A value of p < 0,05 was 
considered to represent a significant 
difference.  
Results 
Binding of [3H]ZM 241385 to the 
Striatum 
The pharmacological characterization of 
adenosine A2A receptors in the striatum 
has been previously determined for wild-
type animals and comparison was made 
between young adult rats and aged rats 
(Lopes et al., 1999a, b). In the present 
study, we characterized the A2AR in the 
transgenic overexpressing rats and 
compared the results to those of wild-
type animals. 
As it was expected, the Bmáx. of [3H]ZM 
241385 was higher in the transgenic 
animals 1249±79 fmol/mg than that of 
wild-type animals 931.6±72.9 fmol/mg. 
The KD determined in both animals didn’t 
show any significant difference, 
0.123±0.045 nM for the transgenic 
animals and 0.106±0.05 nM for wild-type 
animals, with a p-value of 0.4992 (n=3; 
Fig.1) 
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Binding of [3H]ZM 241385 to the 
Hippocampus 
The pharmacological characterization of 
adenosine A2A receptors in the 
Hippocampus was determined for the first 
time in the present study, because the 
basal expression of these receptors in 
the hippocampus of wild-type animals is 
very low.  
 
 
 
Again, as it was expected, the Bmáx. of 
[3H]ZM 241385 displayed the high 
density of these receptors in the 
transgenic animals with 731.2±156.1 
fmol/mg. The KD determined was 
0.62±0.39 nM which represents a 
significant difference from the affinity 
profile of the receptor in the striatum, with 
a p-value of 0.0023 (n=3; Fig.1). 
Saturable binding profile in the 
hippocampus of wild-type animals was 
absent.  
G protein coupling of adenosine A2A 
receptors  
We investigated the G protein coupling of 
A2A receptors using competition binding 
assays in which we tested the 
displacement of [3H]ZM241385  binding 
produced by the tested competitor 
[H3]CGS21680, in the absence and in 
the presence of Gpp(NH)p, which shifts 
high-affinity G-protein coupled receptors 
to low-affinity uncoupled receptors. 
The GTP shift was calculated as the ratio 
of Ki value in the presence of Gpp(NH)p 
per the Ki value in the absence of 
Gpp(NH)p, in order to ascertain whether 
over-expression of A2AR is sufficient to 
produce change in G-protein coupling 
similar to that observed in aged rats. 
 
 
G protein coupling of adenosine A2A 
receptors in the Striatum 
In the wild-type animals, the Ki obtained 
for the samples without Gpp treatment 
was 21.07±3.6 nM  and in those with Gpp 
FIG.1.	   A.	  Saturation binding curves of [3H]ZM 241385 
to the Striatum. the Bmáx. of [3H]ZM 241385 was higher 
in the transgenic animals 1249±79 fmol/mg than that of 
wild-type animals 931.6±72.9 fmol/mg. The KD 
determined in both animals didn’t show any significant 
difference, 0.123±0.045 nM for the transgenic animals 
and 0.106±0.05 nM for wild-type animals, with a p-
value of 0.4992 (n=3). 
B. Saturation binding curves of [3H]ZM 241385 to the 
A2AR in the Hippocampus. The Bmáx. of [3H]ZM 241385 
displayed the high density of these receptors in the 
transgenic animals with 731.2±156.1 fmol/mg. The KD 
determined was 0.62±0.39 nM which represents a 
significant difference from the affinity profile of the 
receptor in the striatum, with a p-value of 0.0023 (n=3). 
Saturable binding profile in the hippocampus of wild-
type animals was absent. 
	  
A	  
B	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it was 34.93±5.3 nM. Therefore, the 
GTPshift calculated is 166%. 
 
 
 
 
 
 
 
 
In the transgenic animals the Ki obtained 
for the samples without Gpp treatment 
was 16.27±3 nM and in those with Gpp it 
was 31.59±5,3 nM. Therefore, the 
GTPshift calculated is 194%. 
The statistical analysis determined a 
significant difference in the comparison of 
A2AR’s affinity in transgenic and wild-type, 
with a p-value of 0.0314 (n=4; Fig.2). 
 
G protein coupling of adenosine A2A 
receptors in the Hippocampus 
The Ki obtained for the samples without 
Gpp treatment was 49.58±14.6 nM and in 
those with Gpp it was 104.5±30.4 nM. 
Therefore, the GTPshift calculated is 
211% (Fig. 3) 
Statistical analysis showed significant 
difference between the affinity of A2AR in 
the striatum and in the hippocampus, with 
a p-value of 0.0134 (n=4). 
 
 
 
 
 
 
FIG.2. A.Displacement binding curves of 
[3H]ZM241385  by [H3]CGS21680 in the Striatum 
of WT animals in the presence of Gpp(NH)p. The 
Ki obtained for the samples without Gpp treatment 
was 21.07±3.6 nM  and in those with Gpp it was 
34.93±5.3 nM. Therefore, the GTPshift calculated 
is 166%. 
B. Displacement binding curves of [3H]ZM241385  
by [H3]CGS21680 in the Striatum of TG animals 
in the presence of Gpp(NH)p. The Ki obtained for 
the samples without Gpp treatment was 
49.58±14.6 nM and in those with Gpp it was 
104.5±30.4 nM. Therefore, the GTPshift 
calculated is 211%. 
Statistical analysis showed significant difference 
between the affinity of A2AR in the striatum and in 
the hippocampus, with a p-value of 0.0134 (n=4). 
C. Comparison of Displacement binding curves of 
[3H]ZM241385  by [H3]CGS21680 in the Striatum 
of TG and WT animals. 
FIG.3. Displacement binding curves of 
[3H]ZM241385  by [H3]CGS21680 in the 
Hippocampus of TG animals in the presence of 
Gpp(NH)p. The Ki obtained for the samples without 
Gpp treatment was 49.58±14.6 nM and in those 
with Gpp it was 104.5±30.4 nM. Therefore, the 
GTPshift calculated is 211%. Statistical analysis 
showed significant difference between the affinity of 
A2AR in the striatum and in the hippocampus, with 
a p-value of 0.0134 (n=4). 
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Discussion 
The major conclusion derived for the 
present study is that over-expression of 
A2A receptors in the brain is able to 
produce modification of G-protein binding 
profile with increased coupling to the 
receptor in the brain regions of Striatum 
and Hippocampus. 
The previous conclusion was derived 
from the observation of significant 
difference in the G-protein binding profile 
between wild-type and transgenic 
animals. In the wild-type animals, 
decoupling of G-protein produced 166% 
fold-change in the displacement of A2AR 
ligand whereas in the transgenic animals 
it produced a 194% fold-chang. Analytical 
comparison showed significant difference 
(p-value of 0,03) between these values. 
The relevance of these results is related 
to the observation of functional and 
structural changes in A2AR of aged rats 
with increased density and G-protein 
coupling, being clear so far that these 
changes in adenosine receptors are 
paralleled by a detriment in behavioral 
patterns and cognitive function. 
Consequently, the increased G-protein 
binding produced exclusively by 
transgenic over-expression of A2AR, 
undeniably confirms the influence of 
over-expression in the increased G-
protein coupling to the A2AR observed in 
the aged groups studied in the literature 
(Lopes et al., 1999b). 
However, the effect of decoupling of G-
protein in the aged groups studied in the 
literature produced 321% fold-change in 
the displacement of A2AR ligand in 
comparison to the 199% observed in the 
transgenic animals. Therefore, age-
related change in the G-protein binding to 
A2A receptor, produces greater coupling 
profile than merely transgenic over-
expression of the receptor. 
These results suggest the contribution of 
multiple factors to the modification of G-
protein binding profile namely other 
intracellular pathways or other 
neuromodulatory systems and, 
consequently, the pathological phenotype 
of diseased animals.  
To this point, it is relevant to emphasize 
that even though the over-expression 
produced only modest G-protein binding 
profile modification, its effects were 
sufficient to produce pathological 
fenotype, established by the working 
memory deficits revealed by the 
transgenic rat strain, TGR, 
overexpressing adenosine A2ARs 
(Giménez-Llort et al., 2007). The reasons 
appointed for phenomenon are that 
adenosine binding to a membrane with 
high density of A2A receptors produces 
the same physiological neuronal 
modulation as a membrane with modest 
density of A2A receptors but a strong G-
protein binding profile, as it is observed in 
the aged rats previously studied (see 
(Lopes et al., 1999b).  
Finally, another major conclusion 
derived from the present study was the 
determination of A2A receptor affinity in 
the Hippocampus.  
Our knowledge about the role of A2ARs 
in modulating neuronal activity is more 
limited. This is mainly because most of 
the studies have focused in the basal 
ganglia where A2ARs are by far more 
abundant because of their ‘abnormal’ 
large expression in the medium spiny 
neurons of the indirect pathway. Thus, 
the study of these A2ARs, which have a 
particular density and subcellular 
localization in this particular set of 
neurons, might not be representative of 
the more general role of A2ARs in the 
most regions of the brain (Cunha, 
2005). 
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In this project comparison has been 
made between affinity of A2AR in 
transgenic animals in the striatum and in 
the hippocampus and showed significant 
difference between this groups with a p-
value of 0.0134 for fitting. These results 
show us that affinity for the A2AR differs 
throughout the brain. Currently, no 
explanation for this phenomenon has 
been conclusively ascertained, however, 
it is believed that these results express a 
property of A2AR that has been recently 
discovered, the heterodimerization with 
A1R (Ciruela et al., 2006). This could 
explain the differences in affinity 
assuming that in the various regions of 
the brain, there are different proportions 
of these heterodimers. 
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Anexes: 
1. Primers used for genotyping and qPCR. 
Primer Target Gene Organism Forward Primer Reverse Primer Amplicon Size 
CypA 
PPIA peptidylprolyl 
isomerase A 
(cyclophilin A) 
rat, 
human TATCTGCACTGCCAAGACTGAGTG CTTCTTGCTGGTCTTGCCATTCC 126bp 
Rpl13A Ribosomal protein L13A rat GGATCCCTCCACCCTATGACA CTGGTACTTCCACCCGACCTC 130bp 
Pgk1 Phosphoglycerate kinase 1 rat ATGCAAAGACTGGCCAAGCTAC AGCCACAGCCTCAGCATATTTC 103bp 
hACTB Human Actin-β human GGACTTCGAGCAAGAGATGG AGCACTGTGTTGGCGTACAG 233bp 
A2AH  Human Adenosine A2A Receptor  human AACCTGCAGAACGTCAC GTCACCAAGCCATTGTACCG 245bp 
A1 Adenosine A1 Receptor  rat ACCTCCGAGTCAAGATCCCT TTGGCTCTCCAGTCTTGCTC 160bp 
Act-B Actin-β rat AGCCATGTACGTAGCCAT CTCTCAGCTGTGGTGGTGAA 228bp 
CaMKII-
hA2A 
calmodulin-dependent 
protein kinase II 
promoter 
and human Adenosine 
Receptor A2A 
transgene GACTAAGTTTGTTCGCATCCC GTGACACCACAAAGTAGTTGG 450bp 
 
